Striving to provide balanced, scientific content related to care of patients with GU malignancies

Uromigos Live 2024: Peri-Operative Therapy in Bladder Cancer


Uromigos Live 2024: Will New Antibody Drug Conjugates Cure Bladder Cancer?

Uromigos Live 2024: T Cell Directed Therapy in Prostate Cancer


Uromigos Live 2024: Radioligands in Prostate Cancer

Uromigos Live 2024: Front-Line Therapy in RCC


Uromigos Live 2024: RCC IO Rechallenge

Topline x Uromigos

KIM-1 is a soluble protein with prognostic and predictive potential in resected RCC.  Data from IMmotion 010 is discussed